Australia Infectious Disease In Vitro Diagnostics Market Size & Outlook
Related Markets
Australia infectious disease in vitro diagnostics market highlights
- The Australia infectious disease in vitro diagnostics market generated a revenue of USD 478.8 million in 2023 and is expected to reach USD 616.6 million by 2030.
- The Australia market is expected to grow at a CAGR of 3.7% from 2024 to 2030.
- In terms of segment, reagents was the largest revenue generating product in 2023.
- Software Services is the most lucrative product segment registering the fastest growth during the forecast period.
Infectious disease in vitro diagnostics market data book summary
| Market revenue in 2023 | USD 478.8 million |
| Market revenue in 2030 | USD 616.6 million |
| Growth rate | 3.7% (CAGR from 2023 to 2030) |
| Largest segment | Reagents |
| Fastest growing segment | Software Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Reagents, Software Services |
| Key market players worldwide | Qiagen NV, Becton Dickinson & Co, BioMerieux SA, Roche Holding AG ADR, Hologic Inc, Abbott Laboratories, QuidelOrtho Corp, Siemens Healthineers AG ADR, Bio-Rad Laboratories Inc, Danaher Corp, OraSure Technologies Inc |
Other key industry trends
- In terms of revenue, Australia accounted for 1.8% of the global infectious disease in vitro diagnostics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China infectious disease in vitro diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- Thailand is the fastest growing regional market in Asia Pacific and is projected to reach USD 143.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Infectious Disease In Vitro Diagnostics Market Scope
Infectious Disease In Vitro Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| OraSure Technologies Inc | View profile | 638 | 220 East First Street, Bethlehem, PA, United States, 18015 | https://www.orasure.com |
| Hologic Inc | View profile | 6990 | 250 Campus Drive, Marlborough, MA, United States, 01752 | http://www.hologic.com |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| QuidelOrtho Corp | View profile | 7100 | 9975 Summers Ridge Road, San Diego, CA, United States, 92121 | https://www.quidelortho.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Siemens Healthineers AG ADR | View profile | 71400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | https://www.siemens-healthineers.com |
| BioMerieux SA | View profile | 13982 | Marcy l’Etoile, Lyon, France, 69280 | http://www.biomerieux.com |
| Becton Dickinson & Co | View profile | 73000 | 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 | https://www.bd.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
Australia infectious disease in vitro diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to infectious disease in vitro diagnostics market will help companies and investors design strategic landscapes.
Reagents was the largest segment with a revenue share of 66.98% in 2024. Horizon Databook has segmented the Australia infectious disease in vitro diagnostics market based on instruments, reagents, software services covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing prevalence of sexually transmissible infections and diseases caused by blood-borne viruses is one of the major factors driving the growth of the market in Australia. Moreover, increasing geriatric population is likely to drive market growth in Australia.
According to the Australian Institute of Health and Welfare, in 2017, about 1 in 7 people in the country was aged 65 years or above, leading to an increase in disease burden. The rising target population, consumer awareness, and technological advancements is expected to drive the market in the near future.
Reasons to subscribe to Australia infectious disease in vitro diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia infectious disease in vitro diagnostics market databook
-
Our clientele includes a mix of infectious disease in vitro diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia infectious disease in vitro diagnostics market, including forecasts for subscribers. This country databook contains high-level insights into Australia infectious disease in vitro diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia Product - Infectious Disease In Vitro Diagnostics Market, 2024 - 2030 (US$M)
Australia Infectious Disease In Vitro Diagnostics Market Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
